Retension Pharmaceuticals (RTSN) vs Spruce Biosciences (SPRB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 18, 2026.
Summary
Retension Pharmaceuticals is the larger company by market cap ($117.2 million vs $114.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | RTSN | SPRB |
|---|---|---|
| Share price | $14.07 | $39.65 |
| Market cap | $117.23M | $113.95M |
| 1-day change | +15.23% | -4.39% |
| YTD return | — | -54.48% |
| 1-year return | — | -74.88% |
| 5-year return | — | -99.84% |
| Forward P/E | — | 7.97 |
| EPS (TTM) | $-2.61 | $-39.12 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $0 |
| Revenue growth (YoY) | — | -100.00% |
| Net income (latest FY) | — | $-38.97M |
| 52-week high | $14.97 | $154.95 |
| 52-week low | $9.66 | $38.06 |
| Distance from 52-week high | -6.02% | -74.41% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +273.27% |
| Average volume | 252.97K | 78.11K |
| Shares outstanding | 8.33M | 2.87M |
| Employees | 12 | 22 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Retension Pharmaceuticals
RTSN stock →Retension Pharmaceuticals, Inc. operates as a clinical -stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees
About Spruce Biosciences
SPRB stock →Spruce Biosciences, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders.
Health Care · Biotechnology: Pharmaceutical Preparations · 22 employees
RTSN vs SPRB FAQ
Which is bigger, Retension Pharmaceuticals or Spruce Biosciences?
Retension Pharmaceuticals (RTSN) is larger, with a market capitalization of $117.23M compared with $113.95M for Spruce Biosciences (SPRB).
Are Retension Pharmaceuticals and Spruce Biosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.